Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
18,942,767
-
Share change
-
+2,237,227
-
Total reported value
-
$5,181,884,338
-
Put/Call ratio
-
130%
-
Price per share
-
$273.63
-
Number of holders
-
313
-
Value change
-
+$614,436,883
-
Number of buys
-
135
-
Number of sells
-
144
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2014
As of 30 Sep 2014 ISHARES TR - ISHARES BIOTECH (IBB) had 313 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,942,767 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, CITIGROUP INC, BANK OF AMERICA CORP /DE/, JPMORGAN CHASE & CO, UBS AG, BARCLAYS PLC, CREDIT SUISSE AG/, CHURCHILL MANAGEMENT Corp, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 313 institutional shareholders of the security as of 30 Sep 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.